Abstract
In the US, marijuana continues to be the most frequently used illicit drug among women of childbearing age, including pregnant and postpartum women. Given the critical window for treatment during the perinatal period, more information is needed about the characteristics of women who abuse marijuana and about their unique needs with the goal of improving clinical services and outcomes for both women and their infants. Objectives: To (1) identify a profile of perinatal women seeking treatment for primarily marijuana abuse and (2) report birth outcomes in a subset of pregnant women with marijuana abuse. Methods: This retrospective clinical chart review study examined 67 adult perinatal women patients (54 % ethnic minority) who attended an inner-city, hospital-affiliated outpatient program specializing in substance abuse treatment for women. Of all pregnant women, 26 % reported positive urine screens during the first trimester, 41 % during the second trimester, and 27 % during the third trimester. While the subset of pregnant women was small, exploratory results suggest that infants whose mothers continued to use marijuana during their pregnancies were born at a lower gestational age than mothers who abstained; t(29) = 2.04, p <0.05. Conclusion: Identifying potential barriers to treatment could help improve retention in community-based treatment programs during pregnancy and the postpartum period.
This is a preview of subscription content, log in via an institution to check access.
References
Bailey BA, McCook JG, Hodge A, McGrady L (2012) Infant birth outcomes among substance using women: why quitting smoking during pregnancy is just as important as quitting illicit drug use. Matern Child Health J 16(2):414–422
Coleman-Cowger V (2012) Mental health treatment need among pregnant and postpartum women/girls entering substance abuse treatment. Psychol Addict Behav 26(2):345–350
De Moraes Barros MC, Guinsburg R, de Araujo PC, Mitsuhiro S, Chalem E, Laranjeira RR (2006) Exposure to marijuana during pregnancy alters neurobehavior in the early neonatal period. J Pediatr 149(6):781–787
El-Mohandes A, Herman A, El-Khorazaty M, Katta P, White D, Grylack L (2003) Prenatal care reduces the impact of illicit drug use on perinatal outcomes. J Perinatol 23:354–360
English DR, Hulse GK, Milne E, Holman CD, Bower CI (1997) Maternal cannabis use and birth weight: a meta-analysis. Addiction 92(11):1553–1560
Gray T, Eiden R, Leonard K, Connors G, Shisler S, Huestis M (2010) Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth. Clin Chem 56(9):1442–1450
Grella C (1996) Services for perinatal women with substance abuse and mental health disorders: the unmet need. J Psychoactive Drugs 29(1):67–78
Haug N, Svikis D, DiClemente C (2004) Motivational enhancement therapy for nicotine dependence in methadone-maintained pregnant women. Psychol Addict Behav 18(3):289–292
Huizink A, Ferdinand R, Ormel J, Verhulst F (2006) Hypothalamic-pituitary-adrenal axis activity and early onset of cannabis use. Addiction 101(11):1581–1588
Jones H, Haug N, Silverman K, Stitzer M, Svikis D (2001) The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug Alcohol Depend 61(3):297–306
Leech SL, Larkby CA, Day R, Day NL (2006) Predictors and correlates of high levels of depression and anxiety symptoms among children at age 10. J Am Acad Child Adolesc Psychiatry 45(2):223–230
Mullins S, Suarez M, Onderma S, Page M (2004) The impact of motivational interviewing on substance abuse treatment retention: a randomized control trial of women involved with child welfare. J Subst Abus Treat 27(1):51–58
O’Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A (1996) Evaluation of a cognitive-behavioral intervention for pregnant injecting drug users at risk of HIV infection. Addiction 91(8):1115–1125
Ordean A, Kahan M (2011) Comprehensive treatment program for pregnant substance users in a family medicine clinic. Can Fam Physician 57:e430–e435, 17. 16
Silverman K, Svikis D, Eobles E, Stitzer M, Bigelow G (2001) A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp Clin Psychopharmacol 9(1):14–23
Substance Abuse and Mental Health Services Administration (SAMHSA) (2010) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings.
Svikis D, Lee J, Haug N, Stitzer M (1997) Attendance incentives for outpatient treatment: effects in methadone- and non-methadone-maintained pregnant drug dependent women. Drug Alcohol Depend 48(1):33–41
Terplan M, Lui S (2008) Psychosocial interventions for pregnant women in outpatient illicit drug treatment programs compared to other interventions. Cochrane Database Syst Rev(4)
Van Gelder M, Reefhuis J, Caton A, Werler M, Druschel C, Roeleveld N (2010) Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study. Drug Alcohol Depend 109(1–3):243–247
Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant B, Hasin D (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65(7):805–815
Yonkers K, Forray A, Howell H, Gotman N, Kershaw T, Rounsaville B, Carroll K (2012) Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery. Gen Hosp Psychiatry 34(5):439–449
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tzilos, G., Hess, L., Kao, J.CW. et al. Characteristics of perinatal women seeking treatment for marijuana abuse in a community-based clinic. Arch Womens Ment Health 16, 333–337 (2013). https://doi.org/10.1007/s00737-013-0358-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00737-013-0358-7